Literature DB >> 19521556

Prolongation of life in anephric rats following de novo renal organogenesis.

Sharon A Rogers1, Marc R Hammerman.   

Abstract

One solution to the shortage of human organs available for transplantation envisions growing new organs in situ. This can be accomplished by transplantation of developing organ anlagen/primordia. Allotransplantation of embryonic day 15 metanephroi into the omentum of adult hosts is followed by differentiation, growth, vascularization and function of the implants. Here we show that survival of rats with all native renal mass removed can be increased by prior metanephros transplantation and ureteroureterostomy. Excretion of urine formed by metanephroi is prerequisite for enhanced survival. This is the first demonstration that life can be extended following de novo renal organogenesis.

Entities:  

Keywords:  cell therapy; end-stage renal disease; kidney; metanephros; transplantation

Year:  2004        PMID: 19521556      PMCID: PMC2633670          DOI: 10.4161/org.1.1.1009

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.500


  20 in total

1.  Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is accompanied by a profile of gene expression similar to normal human kidney development.

Authors:  Benjamin Dekel; Ninette Amariglio; Naftali Kaminski; Arnon Schwartz; Elinor Goshen; Fabian D Arditti; Ilan Tsarfaty; Justen H Passwell; Yair Reisner; Gideon Rechavi
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

Review 2.  Stem cells in the kidney.

Authors:  Qais Al-Awqati; Juan A Oliver
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

Review 3.  Xenotransplantation and other means of organ replacement.

Authors:  M Cascalho; J L Platt
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

4.  Transplantation of metanephroi after preservation in vitro.

Authors:  S A Rogers; M R Hammerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-08       Impact factor: 3.619

Review 5.  Transplantation of renal precursor cells: a new therapeutic approach.

Authors:  M R Hammerman
Journal:  Pediatr Nephrol       Date:  2000-06       Impact factor: 3.714

6.  Effects of growth hormone and IGF-I on renal function in rats with normal and reduced renal mass.

Authors:  S B Miller; V A Hansen; M R Hammerman
Journal:  Am J Physiol       Date:  1990-11

7.  Transplantation of metanephroi across the major histocompatibility complex in rats.

Authors:  S A Rogers; H Liapis; M R Hammerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-01       Impact factor: 3.619

8.  Human and porcine early kidney precursors as a new source for transplantation.

Authors:  Benjamin Dekel; Tatyana Burakova; Fabian D Arditti; Shlomit Reich-Zeliger; Oren Milstein; Sarit Aviel-Ronen; Gideon Rechavi; Nir Friedman; Naftali Kaminski; Justen H Passwell; Yair Reisner
Journal:  Nat Med       Date:  2002-12-23       Impact factor: 53.440

9.  Induction of specific unresponsiveness to cardiac allografts by short-term administration of anti-T cell receptor alpha beta antibody.

Authors:  M Tsuchida; H Hirahara; Y Matsumoto; T Abo; S Eguchi
Journal:  Transplantation       Date:  1994-01       Impact factor: 4.939

Review 10.  Xenogeneic cell therapy: current progress and future developments in porcine cell transplantation.

Authors:  A S Edge; M E Gosse; J Dinsmore
Journal:  Cell Transplant       Date:  1998 Nov-Dec       Impact factor: 4.139

View more
  25 in total

Review 1.  Repopulation of decellularized whole organ scaffold using stem cells: an emerging technology for the development of neo-organ.

Authors:  Aleem Ahmed Khan; Sandeep Kumar Vishwakarma; Avinash Bardia; J Venkateshwarulu
Journal:  J Artif Organs       Date:  2014-07-17       Impact factor: 1.731

Review 2.  Current Bioengineering and Regenerative Strategies for the Generation of Kidney Grafts on Demand.

Authors:  Ximo García-Domínguez; Jose S Vicente; Cesar D Vera-Donoso; Francisco Marco-Jimenez
Journal:  Curr Urol Rep       Date:  2017-01       Impact factor: 3.092

3.  From human pluripotent stem cells to functional kidney organoids and models of renal disease.

Authors:  Susan J Kimber; Adrian S Woolf
Journal:  Stem Cell Investig       Date:  2018-07-21

4.  Functional Human Podocytes Generated in Organoids from Amniotic Fluid Stem Cells.

Authors:  Christodoulos Xinaris; Valentina Benedetti; Rubina Novelli; Mauro Abbate; Paola Rizzo; Sara Conti; Susanna Tomasoni; Daniela Corna; Michela Pozzobon; Daniela Cavallotti; Takashi Yokoo; Marina Morigi; Ariela Benigni; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-10-29       Impact factor: 10.121

5.  Engineering liver tissue from induced pluripotent stem cells: a first step in generating new organs for transplantation?

Authors:  Ira J Fox; Stephen A Duncan
Journal:  Hepatology       Date:  2013-10-31       Impact factor: 17.425

6.  Urine excretion strategy for stem cell-generated embryonic kidneys.

Authors:  Shinya Yokote; Hitomi Matsunari; Satomi Iwai; Shuichiro Yamanaka; Ayuko Uchikura; Eisuke Fujimoto; Kei Matsumoto; Hiroshi Nagashima; Eiji Kobayashi; Takashi Yokoo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

7.  Xenotransplantation of pancreatic and kidney primordia-where do we stand?

Authors:  Marc R Hammerman
Journal:  Transpl Immunol       Date:  2008-11-06       Impact factor: 1.708

8.  Organogenesis of kidney and endocrine pancreas: the window opens.

Authors:  Marc R Hammerman
Journal:  Organogenesis       Date:  2007-10       Impact factor: 2.500

Review 9.  Transplantation of renal primordia: renal organogenesis.

Authors:  Marc R Hammerman
Journal:  Pediatr Nephrol       Date:  2007-08-01       Impact factor: 3.714

Review 10.  Directed differentiation of pluripotent stem cells to kidney cells.

Authors:  Albert Q Lam; Benjamin S Freedman; Joseph V Bonventre
Journal:  Semin Nephrol       Date:  2014-06-13       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.